Kaiser Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.42 M
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 M
- Revenue Growth -9.52%
- Profit Growth -54.98%
- Ebitda -24.18%
- Net Worth 20.88%
- Total Assets 7.47%
About Kaiser Drugs
Kaiser Drugs Private Limited (KDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 April 1999 and has a history of 25 years and ten months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.42 M.
The company currently has active open charges totaling ₹2.20 M.
Vijay Agarawal, Naresh Agarwal, Archana Agarwal, and One other member serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110UP1999PTC024379
- Company No.
024379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does Kaiser Drugs Private Limited offer?
Kaiser Drugs Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antibacterial Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Kaiser Drugs?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Agarawal  | Director | 26-Apr-1999 | Current |
| Naresh Agarwal | Director | 26-Apr-1999 | Current |
| Archana Agarwal | Director | 26-Apr-1999 | Current |
| Dinesh Agarwal | Director | 26-Apr-1999 | Current |
Financial Performance of Kaiser Drugs.
Kaiser Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.52% decrease. The company also saw a substantial fall in profitability, with a 54.98% decrease in profit. The company's net worth Soared by an impressive increase of 20.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaiser Drugs?
In 2023, Kaiser Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.20 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.12 Cr
- Union Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2012 | Hdfc Bank Limited | ₹1.20 M | Open |
| 27 Dec 2002 | Union Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Kaiser Drugs?
Kaiser Drugs has a workforce of 26 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaiser Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaiser Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.